Evaluation of a Connected Interface to Improve the Quality of Life and the Disability of Patient With Rheumatic Diseases
Megadott ok: Problems encountered with the device used in the study
Key facts
- Where
- Montpellier, FranciaországSee the site
Where in Franciaország
- Centre Hospitalier Universitaire de MontpellierMontpellier, FranciaországNo longer taking part
Trial details
- Who runs it
- University Hospital, Montpellier
- Trial code
- NCT05417477
- Record updated
- 2026. november 10.
- Original description
Musculoskeletal pathologies constitute a major public health problem. Rheumatologists, whether they practice in private or hospital settings, play a major role in the management of responsible for these ailments.Read full original descriptionShow less
Evaluation of a Connected Interface (Rheumatologist, Physiotherapist, Patient) to Improve the Quality of Life and the Disability of Patients With Rheumatic Diseases
Musculoskeletal pathologies constitute a major public health problem. Rheumatologists, whether they practice in private or hospital settings, play a major role in the management of responsible for these ailments.
Due to the increase in life expectancy, an increase in the number of consultations can be expected. It is therefore imperative that the latter be more efficient, without losing quality.
Communication between doctor and patient is bound to evolve due to the multiplicity of IT tools available and those that are emerging, which are increasingly essential, including many smartphone applications. Each targeting a specific pathology (rheumatoid arthritis, ankylosing spondylitis, osteoporosis osteoarthritis, they will allow the patient to self-assess, thus becoming an actor in his own care.
A "facilitated" exchange between caregivers and patients would be relevant and would provide added value for all. This is the reason why there is a real need for an application listing precise information on the patient, in a sufficiently succinct way to optimize their transmission to the physiotherapist.
Inclusion: Patients aged 18 to 70 years; Presence of a chronic inflammatory rheumatism (rheumatoid arthritis, axial and/or peripheral spondyloarthritis) or osteoarthritis disease requiring the initiation of at least 20 sessions of physical therapy; Diagnostic confirmation left to the discretion of the investigating physician; Accessibility of an internet network (compatible with smartphone and/or computer); Information and consent of the patient.
Exclusion: Patient refusing or unable to give consent: patient under guardianship or curator, mentally retarded, dementia, language barrier; Pregnant or breastfeeding women; Patient not affiliated to a social security scheme; Patient under legal protection.